How is it that, even when proteins cannot fold on their own in vitro, they somehow fold beautifully in the much more complex environment of a cell? As with most breakthrough discoveries in biology, the answer is remarkably simple: the cell provides special protein machinery, called molecular chaperones, that surrounds the folding protein and removes it from the rest of the cell.
The surfaces of this remarkable machinery are very forgiving. They actually utilize metabolic energy (i.e., ATP hydrolysis) to alternate their physical chemistry between hydrophobic states and hydrophilic states, which restarts the folding when it stalls and expels the protein when folding is completed. In the case of the heat shock protein 60 (Hsp60), a molecular chaperone shaped like a test tube, access to the cavity is highly selective and limited to only nascent proteins or those purposely unfolded to repair conformational damage. Analogous specialized test tube environments, also based on limited access to the internal cavity of a ring-based protein structure, enable targeted proteolysis (by proteosomes), making this strategy a general principle in cellular biology.
These singular discoveries are celebrated in this year's Lasker Basic Medical Research Award to F.-Ulrich Hartl and Arthur Horwich. In collaborative work, they discovered the fundamental principle that protein folding in the cell is generally a facilitated process, and in independent and often complementary work, they and their collaborators established the pathway and molecular mechanisms involved in this process. Together, the discoveries of Hartl and Horwich stand at the apex of decades of work by many investigators who helped start and extend the field of protein folding in the cell.
The pathway of protein folding is utterly general; it is essentially the same in bacteria, fungi, plants, animals, and of course humans. The full implication of the latter is that when the pathway is saturated, or its coupling to the pathway of protein degradation is imperfect, then protein aggregates accumulate in the cell. Depending on the nature of the protein species involved, this can result in neurodegenerative disease, such as Alzheimer's, Huntington's, Creutzfeld Jacob's, and Parkinson's Diseases, or can affect other tissues, as in cystic fibrosis.
Freeing Proteins to Fold
The achievements of Hartl and Horwich must be seen in a historical perspective. In 1972, Christian Anfinsen received a Nobel Prize for discovering in the 1950s that proteins assume their three-dimensional conformations and therefore gain their catalytic potential, exclusively based on primary instructions in their intrinsic amino acid sequence. This insight forged the link between the genetic code and protein function, but it emerged from simple denaturation-renaturation experiments involving a small number of isolated, pure enzymes, which at that time were rather simple and small. As more complex genes have been analyzed and expressed over time, it has become common knowledge that most complex proteins are notoriously difficult to refold at concentrations present in cells and at the bulk concentration of protein that prevails in cells. Indeed, many proteins even fold poorly when expressed inside cells from distant species.
Molecular chaperones provide the solution to this paradox. In many cases, chaperones, such as the Hsp70 chaperone system, stabilize aggregation-prone (i.e., hydrophobic) intermediates. In more difficult cases, tube-like chaperones, such as the GroEL/Hsp60 chaperone system, funnel the polypeptide into the protected internal space of giant ring-based structures. These two strategies represent the basic principles that permit proteins to fold in the cell, and the establishment of the mechanisms and pathways involved represents, in our time, an advance comparable to that made by Anfinsen in his time.
Indeed, these advances are strictly complementary. Anfinsen's fundamental chemical conclusion-that a protein's threedimensional shape is determined solely by its intrinsic chemical composition-is in no way challenged by Hartl's and Horwich's singular advance in cell biology. To the contrary, molecular chaperones associate with their substrates only during the folding process, and thus they are purely facilitators that enable a gene product to efficiently achieve its final folded state dictated solely by its intrinsic chemistry.
Landmark Papers Set the Stage
Over the past 40 years, many investigators have identified and characterized individual components of what we now recognize as the core chaperone protein machinery, including phage assembly factors and proteins upregulated by stress. And, by the late 1980s, all the proteins central for protein folding were virtually known in both structural and broad phenotypic terms. In particular, John Ellis, Costa Georgopoulos, and George Lorimer deserve special recognition for their genetic and biochemical description of the ''protein-folding catalysts.'' Georgopoulos was the first to define the genes for all the major folding catalysts. His work as a graduate student in the early 1970s and then later as a postdoctoral fellow led to the mapping of the E. coli genes GroEL, GroES, DnaK, DnaJ, and GrpE. These genes all emerged from genetic screens for mutants that affect l phage assembly and, in the case of the latter three genes, play a role in phage and chromosome replication (Georgopoulos and Herskowitz, 1971) .
In an entirely independent development, in 1980 Ellis discovered the first molecular chaperone (Barraclough and Ellis, 1980) . He found that unassembled subunits of the Rubisco enzyme complex in chloroplasts were associated with another protein that turned out to be a chaperone. In 1988, Ellis and Georgopoulos discovered that this chaperone is related to the GroEL molecule involved in phage assembly (Hemmingsen et al., 1988) . Ellis coined the term ''chaperonin'' for the GroE-type folding catalysts that are required to assist a variety of cellular processes within organelles and in the cytoplasm of all types of cells. The following year and in subsequent detailed enzymologic studies, George Lorimer reconstituted the assembly of Rubisco subunits with isolated bacterial chaperonins (Goloubinoff et al., 1989) .
These foundational studies beautifully set the stage for Hartl's and Horwich's two landmark papers in 1989. In a key genetic and biochemical experiment, Hartl and Horwich isolated and characterized mutations in mitochondrial chaperone Hsp60/GroEL. Surprisingly, mitochondrial proteins were synthesized and imported successfully, but they failed to fold. This was the first proof that protein folding required molecular assistance by binding proteins (''chaperones'') in the living cell (Cheng et al., 1989) . The same team published a second landmark paper (Ostermann et al., 1989) showing that mitochondrial Hsp60 from mitochondria assists the folding of monomeric polypeptide chains and requires ATP binding and hydrolysis to do so. This work focused on the folding of dihydrofolate reductase (DHFR) when it's imported into isolated mitochondria, and it established the principle of assisted folding in the cell for single polypeptide chains, even those that can fold spontaneously and efficiently as pure proteins. This marked a radical departure from the earlier view that protein folding in the cell can be a spontaneous process. It is on the basis of these papers and their future seminal contributions in establishing the key concepts and molecular mechanisms in cellular protein folding that Horwich and Hartl stand out (Figure 1) .
It is noteworthy that this remarkable set of experiments was possible only because of previous mechanistic insights into how proteins encoded in the nucleus are imported into mitochondria. These insights emerged mainly from the laboratories of Walter Neupert and Gottfried Schatz in the previous decade. Not only was Hartl a proté gé of Neupert, but much of his early work on the Hsp60 chaperones was carried out directly in Neupert's laboratory, as reflected in Neupert's coauthorship of the landmark papers. Schatz and collaborators introduced the background methods involving DHFR translocation and folding.
Hsp70s and Folding in the Cytoplasm
The Hsp70 protein family provides a second system of molecular chaperones. These proteins are a family of monomeric ATPases, with Georgopoulos' bacterial DnaK (an Hsp70) and its cofactors DnaJ and GrpE as the prototype of these chaperones. In all likelihood, the Hsp70 chaperones supply the most general mechanism of facilitated protein folding, as the GroEL system is required for only a small fraction of the cell's proteins (Houry et al., 1999) .
Key experiments in the laboratories of Hugh Pelham and Elizabeth Craig first associated the Hsp70 proteins with protein folding in the cytoplasm and in quality control inspection in the secretory pathway. The DnaK proteins are related to a family of heat-induced proteins, called the Hsp70s, which were first described as heat shock proteins in Drosophila. Rothman and colleagues discovered that the Hsp70s bind and hydrolyze ATP (Chappell et al., 1986) . With this in mind, Pelham was the first to speculate that Hsp70s promote proper folding or reassembly of proteins by using cycles of ATP hydrolysis to bind and release aggregated, denatured proteins (Pelham, 1986) . Pelham was also the first to The Hsp70 chaperones DnaK/DnaJ stabilize the newly synthesized protein in a nonaggregated, folding-competent state. Transferring the protein into the central cavity of the Hsp60 chaperone GroEL requires the nucleotide exchange factor GrpE. GroES binds to GroEL in an ATP-dependent reaction and displaces the unfolded protein into an enclosed folding cage. The protein is allowed to fold inside the cage for 10 s, the time needed for GroEL to complete one round of ATP hydrolysis (of 7 ATPs). Binding of ATP to the opposite ring of GroEL induces an allosteric change that triggers the opening of the folding chamber. Folded protein is released, whereas incompletely folded protein re-binds to GroEL for another round of attempted folding in the GroEL-GroES cage.
demonstrate that BiP, an Hsp70 ATPase in the endoplasmic reticulum lumen, was associated with the assembly of secretory proteins that fold in the ER (Munro and Pelham, 1986) , implicating Hsp70s in the folding process. The core biochemical mechanism-binding and release of exposed hydrophobic segments-was established by Rothman and colleagues (Flynn et al., 1989) . Elizabeth Craig developed a yeast genetic approach to discover the roles of the cytoplasmic Hsp70s in maintaining the unfolded state that favors protein translocation (Deshaies et al., 1988) .
Hartl and Horwich Hook Up the Pathway
As important as these early discoveries were in the developing the story of in vivo protein folding, the experiments of Hartl and Horwich from 1987 to 1997 created a coherent picture of the physiologic and biophysical processes that cells use to fold proteins. In an extraordinary body of work between 1991 and 1994, Hartl defined, resolved, and reconstituted the complete pathway by which molecular chaperones cooperate to fold proteins. In a brilliant series of articles published in the journal Nature, he linked together the entire pathway, establishing how the folding peptide chain is recognized cotranslationally by Hsp70, preventing premature misfolding (the negative role) (Langer et al., 1992a; Frydman et al., 1994) , and then transferred sequentially from Hsp70 to Hsp60/GroEL, which promotes folding (the positive role). He also then placed in this context many other (''cochaperone'') proteins that act as regulators of the steps in this pathway (DnaJ, GrpE, GroES).
For most proteins, Hsp70 is essentially sufficient. The Hsp70 loads onto the newly synthesized polypeptide chain as it emerges from the ribosome and stays on long enough to allow entire folding domains to be manufactured, thereby preventing aggregation. It further imparts energy to the polypeptide as it releases it, giving folding reactions an extra kick. When this does not suffice, the chain (with Hsp70 re-bound to it) is transferred to the chamber of a GroEL chaperonin to do the heavy lifting.
By this time, both GroEL (Hendrix, 1979) and proteosomes (Dahlmann et al., 1986) were well known to be cylindrical particles based on oligomeric ring-forming subunits. This of course gave rise to speculation that the cavities may have functional significance. But the cylindrical shape of the particle did not intrinsically require that folding (or degradation) occur within the particle, as a cavity is a structural consequence of any ring-based oligomer. Direct evidence for this hypothesis came first for protein folding inside GroEL in 1992 (and then 3 years later for protein degradation inside proteosomes in 1995).
Electron microscopy images of GroEL, taken by Hartl and Baumeister (Langer et al., 1992b) , offered the first indication that folding occurs within the GroEL cavity, and this hypothesis was confirmed in 1993 by Horwich (Braig et al., 1993) . Hartl proposed that the chain folds in the internal microenvironment provided by the cavity of Hsp60/GroEL and its lidshaped cofactor GroES (Martin et al., 1993) . In essence, a series of ATP-driven conformational steps change the shape of the wall of the chamber and ''cock and load'' the two symmetrical half chambers in this molecule. In other words, ATP binding and hydrolysis drive conformational changes that open the chamber to accept an unfolded domain and then closes the chamber to reinforce the folding event. Although at first controversial, this beautiful mechanism is now well accepted and thoroughly confirmed by X-ray crystal structures of the Hsp60/ GroEL and related proteins.
In 1994, together with Paul Sigler, Horwich solved the X-ray crystal structure of GroEL, which was one of the largest protein complexes crystallized at the time (Braig et al., 1994 ). An elegant mutational analysis then confirmed, on a structural basis, that an unfolded protein binds in the center of the hollow cylindrical GroEL complex by hydrophobic binding regions on the apical GroEL domains facing the central cavity (Fenton et al., 1994) . The ATP-binding sites were also observed as pockets in the equatorial domain of each subunit.
More details followed in 1997, when Horwich and Sigler solved the crystal structure of the GroEL-GroES complex . The structure confirmed that the inner cavity of GroEL undergoes a massive conformational change upon GroES binding. This change results in the burial of the hydrophobic regions and formation of a large hydrophilic chamber in which proteins up to about 60 kDa in size are free to fold. This structure also identified the mechanism of ATP hydrolysis, allowing the Horwich laboratory to work out the nucleotide reaction cycle (Rye et al., 1997 ).
Perspective
Our current understanding of proteinfolding mechanisms is rather precise. However, it has not yet revealed how to control this process when it goes awry in diseases of protein folding, such as Alzheimer's and Huntington's diseases. A new field of ''proteostasis'' seeks to understand the balance of protein folding, misfolding, and proteolysis that governs normal and abnormal cell physiology. Drugs that target the folding process and that stabilize a proper folded state for misfolded proteins, such as mutant forms of CFTR (Cystic Fibrosis Transmembrane Conductance) in cystic fibrosis, show promise in the treatment of a variety of genetic diseases. If we are able to harness our understanding of protein chaperones in the treatment of diseases of protein folding, it will be because of the pioneering efforts of Hartl, Horwich, and others who elevated the field to its current level of molecular precision.
